Honorees of the 2018 A Second Helping of Life: Jane E. Brody and Pfizer Inc.

We are pleased to honor Jane E. Brody and Pfizer Inc. (accepted by Frank D'Amelio) this year at the 15th anniversary of A Second Helping of Life!  Get tickets to the event here. 

Jane E. Brody

Jane E. Brody is the Personal Health columnist for The New York Times. She joined The Times as a specialist in medicine and biology in 1965 after completing degrees in biochemistry and science writing at The New York State College of Agriculture and Life Sciences at Cornell University and the University of Wisconsin School of Journalism, respectively, and a two-year stint as a reporter for the Minneapolis Tribune. Her award-winning column is published in The Times’s Science Times section every Tuesday.

Ms. Brody is a much-sought-after speaker who lectures to both lay and professional audiences on issues relating to health and wellness, including end-of-life preparation and care. Though no fanatic, when it comes to healthful living, she practices what she preaches, enjoying a diet rich in vegetables, fruits, and whole grains along with fish, lean meats and poultry, and engaging in daily physical activity.

Ms. Brody is the only or principal author of more than a dozen books, including two best-sellers, Jane Brody’s Nutrition Book and Jane Brody’s Good Food Book. She has appeared on hundreds of radio and television programs and starred in her own 10-part show on public television, Good Health from Jane Brody’s Kitchen. She has written scores of magazine articles and won many prestigious awards for journalistic excellence.

Ms. Brody is the mother of twin boys and grandmother of four boys, including a set of twins. Brooklyn born and bred, she resides in New York City.

Pfizer Inc. (Accepted by Frank D'Amelio)

Frank D'Amelio

Frank D’Amelio is the Executive Vice President, Business Operations & Chief Financial Officer of Pfizer, responsible for finance, business development and business operations, including IT, procurement and real estate. Frank led the acquisition and integration of Hospira Inc., King Pharmaceuticals, Wyeth Pharmaceuticals, Anacor Pharmaceuticals, Inc., and Medivation, Inc., as well as the spin-off of Pfizer’s animal health business, Zoetis, and the sale of its nutrition business to Nestle and Capsugel business to KKR.

Before joining the company in September 2007, he was Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent, responsible for the integration of the Alcatel-Lucent merger as well as procurement, real estate, IT and supply chain.

Prior to the merger of Alcatel and Lucent Technologies in 2006, Frank was the Chief Operating Officer of Lucent Technologies. In 2001, he was appointed Executive Vice President and Chief Financial Officer of Lucent, where he helped lead the company through one of the most challenging periods in the telecom industry’s history and returned the company to profitability.

When Lucent was spun off from AT&T in 1996, Frank helped create the new company financially as the CFO of Lucent’s Network Systems Business and was a critical member of the team that met with investors around the world during Lucent’s initial public offering. In 1999, he was appointed the Group President of Lucent’s Switching Solutions Business Unit, where he led Lucent’s multibillion-dollar, global Switching, Access and Application Software businesses.

Born and raised in New Jersey, Frank earned his MBA in Finance from St. John’s University and his bachelor’s degree in Accounting from St. Peter’s University. He started his career in 1979 at Bell Labs, holding a variety of financial, accounting and general management positions, and moved within AT&T, holding a series of positions with increasing responsibility.

In 2005, 2006, 2011, 2012, 2013, 2014, 2016 2017 and 2018, Frank was ranked among America’s top CFOs by Institutional Investor magazine. In 2002, he was recognized by Treasury & Risk Magazine as one of America’s Top CFOs.

He currently serves on the Board of Directors of: Humana, Inc. and is chair of the Audit Committee; Zoetis, Inc.; and the Independent College Fund of New Jersey.


• 2002 Bloomberg University Commencement Keynote Speaker
• 2010 Boy Scouts of America Honoree
• 2011 St. John’s University Beta Gamma Sigma Inductee
• 2011 Autism Speaks/Gillen Brewer School Honoree
• 2012 Distinguished Alumni of St. Peter’s University
• 2012 National Italian American Foundation Honoree
• 2013 Calvary Medal Recipient
• 2014 Rutgers Business School Commencement Keynote Speaker
• 2014 Columbus Citizens Foundation Honoree